SCHEMBL3299174

SCHEMBL3299174

NC(=O)c1cc2c(N3CCNCC3)cccc2n1Cc1ccc(F)cc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 1/20 0.47
HTR6 P50406 6/20 0.45
F10 P00742 2/20 0.43
DRD2 P14416 1/20 0.43
SOS1 Q07889 1/20 0.42
CCR2 P41597 3/20 0.41
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
NPC1 O15118 1/20 0.40
MAPK1 P28482 1/20 0.40
GRM2 Q14416 1/20 0.40
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
HTR7 P34969 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3294093 0.99 HTR3A (0.46) HTR3AHTR6F10DRD2SOS1
SCHEMBL3300405 0.91 F10 (0.47) HTR6F10DRD2HTR7
SCHEMBL3297730 0.90 HTR6 (0.56) HTR3AHTR6F10CCR2KDM4E
Hydrochloric Acid SCHEMBL3297632 0.90 F10 (0.46) HTR6F10DRD2HTR7
Hydrochloric Acid SCHEMBL3304362 0.89 HTR6 (0.55) HTR3AHTR6F10CCR2KDM4E
SCHEMBL3296433 0.87 HTR6 (0.60) HTR6F10DRD2CCR2KDM4E
Hydrochloric Acid SCHEMBL3297278 0.86 HTR6 (0.59) HTR6F10DRD2CCR2KDM4E
SCHEMBL3300925 0.84 HTR1A (0.44) HTR3AHTR6DRD2KDM4ELMNA
Hydrochloric Acid SCHEMBL3299238 0.84 HTR1A (0.43) HTR3AHTR6DRD2KDM4ELMNA
SCHEMBL3298934 0.83 HTR6 (0.45) HTR3AHTR6F10SOS1CCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2084131-A1 INDOLE AND BENZOFURAN 2-CARBOXAMIDE DERIVATIVES F. Hoffmann-Roche AG (CH) 2009-08-05 EP claimed
WO-2008055808-A1 INDOLE AND BENZOFURAN 2-CARBOXAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2008-05-15 WO claimed
US-7741326-B2 for enhancing cognitive memory in an Alzheimer's patient; 5-HT2-selective and 5-HT6 selective ligands ROCHE PALO ALTO LLC (US) 2010-06-22 US disclosed
US-7741326-B2 for enhancing cognitive memory in an Alzheimer's patient; 5-HT2-selective and 5-HT6 selective ligands ROCHE PALO ALTO LLC (US) 2010-06-22 US disclosed
US-7741326-B2 for enhancing cognitive memory in an Alzheimer's patient; 5-HT2-selective and 5-HT6 selective ligands ROCHE PALO ALTO LLC (US) 2010-06-22 US disclosed
US-20080146587-A1 Indole and benzofuran 2-carboxamide derivatives and uses thereof ROCHE PALO ALTO LLC 2008-06-19 US disclosed
US-20080146587-A1 Indole and benzofuran 2-carboxamide derivatives and uses thereof ROCHE PALO ALTO LLC 2008-06-19 US disclosed
US-20080146587-A1 Indole and benzofuran 2-carboxamide derivatives and uses thereof ROCHE PALO ALTO LLC 2008-06-19 US disclosed
WO-2008055808-A1 INDOLE AND BENZOFURAN 2-CARBOXAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2008-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146587-A1 Indole and benzofuran 2-carboxamide derivatives and uses thereof AR, CNR2, CNR1 HTR3A 59/4885HTR6 49/4885F10 2671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.